No Data
No Data
Guangdong Marubi Biotechnology Co., Ltd. (SHSE:603983) Looks Just Right With A 32% Price Jump
CITIC SEC: China's restructuring of collagen globalization accelerates, with "raw materials, cosmetics, and equipment" going global comprehensively.
CITIC SEC released a Research Report stating that the restructured collagen Industry continues to make progress in technology and processes, achieving breakthroughs in type XVII, type IV, and various combinations following types I and III; leading companies have become more mature in their capabilities for structural analysis, fermentation preparation, productization, and commercialization.
Guangdong Marumi Biotechnology Co., Ltd. 2024 Annual Report
Guangdong Marumi Biotechnology Co., Ltd. 2024 Annual Report Summary
Guangdong Marumi Biotechnology Co., Ltd. Report for the first quarter of 2025
Announcement of Guangdong Marumi Biotechnology Co., Ltd. on the main operating data for the first quarter of 2025